3rd line Erlotinib for lung cancer in Asia may be as cost-effective as in the Western world.

Suppr

超能文献

作者信息

Lin Ching-Chan, Hsia Te-Chun, Chien Chun-Ru

出版信息

Lung Cancer. 2012 Jun;76(3):499-500. doi: 10.1016/j.lungcan.2012.03.022. Epub 2012 Apr 13.

DOI:10.1016/j.lungcan.2012.03.022

PMID:22503286

Abstract

摘要

相似文献

3rd line Erlotinib for lung cancer in Asia may be as cost-effective as in the Western world.

Lung Cancer. 2012 Jun;76(3):499-500. doi: 10.1016/j.lungcan.2012.03.022. Epub 2012 Apr 13.

NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer.英国国家卫生与临床优化研究所（NICE）关于厄洛替尼用于表皮生长因子受体酪氨酸激酶（EGFR-TK）突变阳性的晚期或转移性非小细胞肺癌一线治疗的指南。

Lancet Oncol. 2012 Aug;13(8):764-5. doi: 10.1016/s1470-2045(12)70296-6.

Cost-effectiveness of erlotinib versus docetaxel for second-line treatment of advanced non-small-cell lung cancer in the United Kingdom.在英国，厄洛替尼与多西他赛用于晚期非小细胞肺癌二线治疗的成本效益分析

J Int Med Res. 2010 Jan-Feb;38(1):9-21. doi: 10.1177/147323001003800102.

Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: a real-world cost-effectiveness analysis.厄洛替尼或最佳支持治疗用于三线治疗晚期非小细胞肺癌：真实世界的成本效益分析。

Lung Cancer. 2012 Jun;76(3):472-7. doi: 10.1016/j.lungcan.2011.12.003. Epub 2012 Jan 9.

Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer. Rev Port Pneumol 2008; 14(6):803-827.阿劳霍A等人。厄洛替尼、多西他赛、培美曲塞与最佳支持治疗作为非小细胞肺癌二线或三线治疗的经济学分析。《葡萄牙呼吸病学杂志》2008年；14(6):803 - 827。

Rev Port Pneumol. 2009 May-Jun;15(3):555-9; author reply 560-6.

Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan.厄洛替尼用于晚期非小细胞肺癌的评估：对美国一项医疗保险计划预算的影响。

J Manag Care Pharm. 2006 Jul-Aug;12(6):472-8. doi: 10.18553/jmcp.2006.12.6.472.

Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.厄洛替尼、阿法替尼和顺铂-培美曲塞用于美国晚期表皮生长因子受体（EGFR）突变阳性非小细胞肺癌一线治疗的成本效益和信息价值

Value Health. 2015 Sep;18(6):774-82. doi: 10.1016/j.jval.2015.04.008. Epub 2015 Jun 22.

Costs and clinical outcomes among patients with second-line non-small cell lung cancer in the outpatient community setting.二线治疗非小细胞肺癌患者在社区门诊环境下的成本和临床结局。

J Thorac Oncol. 2012 Jan;7(1):212-8. doi: 10.1097/JTO.0b013e3182307f33.

[Financial aspects of targeted therapy of lung cancer as compared to conventional chemotherapy].

Magy Onkol. 2007;51(3):191-6. Epub 2007 Oct 7.

[Gefitinib therapy in advanced non-small cell lung cancer in patients with EGFR mutations: cost-effectiveness analysis].[吉非替尼治疗表皮生长因子受体（EGFR）突变的晚期非小细胞肺癌患者：成本效益分析]

Vopr Onkol. 2015;61(4):676-80.

引用本文的文献

Cost-effectiveness of neoadjuvant concurrent chemoradiotherapy versus esophagectomy for locally advanced esophageal squamous cell carcinoma: A population-based matched case-control study.新辅助同步放化疗与手术治疗局部晚期食管鳞状细胞癌的成本效益：一项基于人群的配对病例对照研究。

Thorac Cancer. 2016 Apr 26;7(3):288-95. doi: 10.1111/1759-7714.12326. Epub 2015 Dec 23.

Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis.化疗联合胸部放疗与单纯化疗治疗局限期小细胞肺癌的成本效果分析：基于人群的倾向评分匹配分析。

Thorac Cancer. 2014 Nov;5(6):530-6. doi: 10.1111/1759-7714.12125. Epub 2014 Oct 23.

Cost and effectiveness of image-guided radiotherapy for non-operated localized lung cancer: a population-based propensity score-matched analysis.影像引导放射治疗非手术局限性肺癌的成本与效果：基于人群的倾向评分匹配分析

J Thorac Dis. 2015 Sep;7(9):1643-9. doi: 10.3978/j.issn.2072-1439.2015.09.36.

Optimal interval of surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: population level evidence in addition to controlled trial.T3-4/N0+期直肠癌新辅助放化疗后的最佳手术间隔时间：除对照试验外的人群水平证据

J Gastrointest Oncol. 2015 Jun;6(3):E38-9. doi: 10.3978/j.issn.2078-6891.2014.106.

Cost and effectiveness of video-assisted thoracoscopic surgery for clinical stage I non-small cell lung cancer: a population-based analysis.电视辅助胸腔镜手术治疗临床I期非小细胞肺癌的成本与效果：基于人群的分析

J Thorac Dis. 2014 Dec;6(12):1690-6. doi: 10.3978/j.issn.2072-1439.2014.10.27.

Questionable role of adjuvant chemotherapy in rectal cancer patients who had reached pathological complete response after neoadjuvant concurrent chemoradiotherapy: no matter in the East or in the West.新辅助同步放化疗后达到病理完全缓解的直肠癌患者中辅助化疗的可疑作用：无论在东方还是西方。

J Cancer Res Clin Oncol. 2014 Sep;140(9):1495-6. doi: 10.1007/s00432-014-1749-5. Epub 2014 Jun 24.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验